医学
酒精性肝病
非酒精性脂肪肝
脂肪肝
内科学
药品
胃肠病学
发病机制
肝病
疾病
慢性肝病
生物信息学
代谢综合征
药理学
肥胖
生物
肝硬化
作者
Lingchong Liu,Yu Wang,Jing Zhang,Chao Wang,Youbao Li,Weichang Dai,Chunhong Piao,Junmei Liu,Hansong Yu,Xia Li,Yuhua Wang,Jingsheng Liu
标识
DOI:10.1080/87559129.2021.1967380
摘要
Alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD) are both serious chronic liver diseases worldwide. The cause of ALD is chronic alcoholism. NAFLD is a metabolic syndrome caused by excessive accumulation of triglycerides in liver cells without consumption of alcohol. Although the pathogeneses of these two liver diseases are different, the traditional treatments for these two liver diseases are mainly drug treatment. Drug treatment works quickly, but long-term use may produce side effects. Studies demonstrated that probiotics as a natural substance played a unique role in improving liver and intestinal health. This review overviews the pathogenesis of ALD and NAFLD, summarizes the health effects of probiotics in the treatment of ALD and NAFLD, and discusses the treating mechanisms of probiotics in order to provide a theoretical basis for future research.
科研通智能强力驱动
Strongly Powered by AbleSci AI